Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zeqi Ji"'
Autor:
Yiyuan Liu, Jinyao Wu, Zeqi Ji, Lingzhi Chen, Juan Zou, Jiehua Zheng, Weixun Lin, Jiehui Cai, Yaokun Chen, Daitian Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background This network meta-analysis aimed to assess the comparative efficacy and safety of combinations involving three cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapies (ETs) in patients with metastatic or advanced b
Externí odkaz:
https://doaj.org/article/801b5bf6496543cdbfd3a5e49679b710
Autor:
Jiaxin Wu, Daitian Zheng, Haiting Wang, Zhongming Zhou, Qiuping Yang, Jinyao Wu, Huiting Tian, Zeqi Ji, Lingzhi Chen, Jiehui Cai, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionBreast cancer remains a significant global health challenge, accounting for 2.3 million new cases in 2020 and ranking as the most prevalent cancer by incidence and the fourth in cancer-related mortality worldwide. In China, breast cancer
Externí odkaz:
https://doaj.org/article/dce3046aa58541c3a075e281f847f851
Autor:
Xizhou Zhang, Jinyao Wu, Qiuping Yang, Huiting Tian, Lingzhi Chen, Daitian Zheng, Zeqi Ji, Jiehui Cai, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Over the past decade, thousands of articles have been published on the mechanistic target of rapamycin (mTOR) and its role in breast cancer. However, the variability and heterogeneity of academic data may impact the acquisition of published research
Externí odkaz:
https://doaj.org/article/78a65d2c87eb4c2fb6e9f8ac812dd0d7
Autor:
Yujie Huang, Daitian Zheng, Qiuping Yang, Jinyao Wu, Huiting Tian, Zeqi Ji, Lingzhi Chen, Jiehui Cai, Zhiyang Li, Yexi Chen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionSince the mid-2000s, breast cancer incidence among women has slowly increased at about 0.5% per year. In the last three decades, Breast Cancer Susceptibility Gene (BRCA) has been proven to be the crucial gene in encouraging the incidence
Externí odkaz:
https://doaj.org/article/772ef5a42483435eb1eebd90277c17e6
Autor:
Zeqi Ji, Lingzhi Chen, Qiuping Yang, Huiting Tian, Jinyao Wu, Daitian Zheng, Jiehui Cai, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundRecently, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC. This paper aims to use bibliometric analysis to investigate the research status and future
Externí odkaz:
https://doaj.org/article/957eddb894b64c2581a1ec0aca4527e8
Autor:
Jinyao Wu, Yaokun Chen, Lingzhi Chen, Zeqi Ji, Huiting Tian, Daitian Zheng, Qiuping Yang, Yiyuan Liu, Jiehui Cai, Jiehua Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day i
Externí odkaz:
https://doaj.org/article/9f13d1d7cd6c40e68f017158c7c0c486